To read more on this topic click here.
Plant-based compounds could treat chronic pain in Parkinson’s, study finds
Author: Sophie BatesPublished: 12 March 2020
Prep: Cook: Serves:
A six-year study has found that chronic pain in people with Parkinson’s is linked to a gene involved with how the brain responds to cannabis compounds.
The investigation examined why some people with the condition experience persistent pain – and the impact it has on their work, daily life and social relationships. Conducted by researchers at Manchester’s Salford Royal Foundation Trust, UK, and funded by Parkinson’s UK, it is the largest study to investigate chronic pain in people with Parkinson’s.
Dr Monty Silverdale, consultant neurologist at Greater Manchester Centre, said: “This study is significant because it shows the important role of genetics in chronic pain in Parkinson’s.
“Our findings suggest that cannabis-based compounds may be worth investigating as a treatment for pain in Parkinson’s.”
Share this story
“Life can still be fun if you have Parkinson’s”
The latest in our monthly series profiling WPC2019 bloggersREAD MORE
Save the last dance for Google Glass
How innovative software is helping patients dance off symptomsREAD MORE
Parkinson’s UK to launch largest plant-based oil trial in the world
The trial will be carried out over three yearsREAD MORE